Boston, MA – November 25, 2019 – Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic device and app technologies for women with pelvic floor disorders, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the next-generation leva® Pelvic Digital Therapeutic for the strengthening of pelvic floor muscles and the treatment of stress, mixed and mild to moderate urgency urinary incontinence (UI) in women.

Study Demonstrates Improvements in Objective Pelvic Floor Muscle Measures, Patient-Reported Urinary Incontinence Severity and Condition-Specific Quality of Life, with Results Evident after 1 Week of Use

Boston, MA – March 28, 2019 – Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced that it has received a nomination for MedTech Company...

Boston, MA – March 14, 2019– Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced Jim O’Connor has been promoted to General Counsel...

Boston, MA – January 9, 2019– Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced John A. Fallon, M.D. has joined its Board of...

Six-Center Study Will Compare Renovia’s Pelvic Digital Therapeutic System to Standard of Care Pelvic Floor Muscle Exercises in Home-based Treatment of Stress-dominant Urinary Incontinence Boston, MA – November 12, 2018 – Renovia Inc. (“Renovia”), a company dedicated...

Boston, MA – October 31, 2018– Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced Tara Butler, M.D. has joined its Board of Directors....

Boston, MA – Sept 12, 2018– Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced Dan Levangie has joined its Board of Directors. "Dan...

Renovia is Developing a Product Pipeline to Better Diagnose and Treat Women Affected by Pelvic Floor Disorders, including Urinary Incontinence Boston, MA – August 28, 2018 – Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital...

Financing Will Accelerate Clinical Research, Development and New Digital Therapeutic Device Launches Targeted at Pelvic Floor Disorders Boston, MA – August 21, 2018 – Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital...

Boston, MA- February 25th, 2018- Renovia, a company dedicated to discovering and delivering innovative medical solutions and technology combined with digital health to help individuals suffering from pelvic floor disorders, announced the appointment of Jim O’Connor as...

Boston, MA – December 13th, 2017 Renovia, a company dedicated to discovering and delivering innovative medical solutions and technology combined with digital health to help individuals suffering from pelvic floor disorders, announced the appointment of Samantha...